Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System
Background : Graft-versus-host disease (GVHD) is a severe complication for transplant patients, particularly those undergoing allogeneic hematopoietic stem cell transplantation. Although various GVHD prophylaxis drug combinations are administered in clinical settings, previous studies have primarily...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society for Transplantation
2025-06-01
|
Series: | Clinical Transplantation and Research |
Subjects: | |
Online Access: | https://www.ctrjournal.org/journal/view.html?doi=10.4285/ctr.24.0049 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!